Multitarget Selective Antidepressants Design: Latest Developments, Opportunities and Challenges

E-ISSN： 1875-6166|8|2|131-142

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.8, Iss.2, 2008-06, pp. : 131-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

On the Paradigm Shift Towards Multitarget Selective Drug Design

Current Computer - Aided Drug Design, Vol. 4, Iss. 2, 2008-06 ,pp. : 76-90

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor (EGFR) and its Cross-Talks with Topoisomerases: Challenges and Opportunities for Multi-Target Anticancer Drugs

Current Pharmaceutical Design, Vol. 22, Iss. 21, 2016-06 ,pp. : 3226-3236

Bentham Science Publishers

Access to resources Recommend Favorite

Antidepressants: new challenges for physicians

Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Antidepressants: Current Strategies and Future Opportunities

Current Pharmaceutical Design, Vol. 16, Iss. 38, 2010-12 ,pp. : 4243-4253

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges and opportunities for new protein crystallization strategies in structure-based drug design

By Grey Jessica Lynn Thompson David H

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1039-1045

Informa Healthcare

Access to resources Recommend Favorite